Skip to main content
Equibles

UBS Group AG

Position in DXCM — Dexcom Inc

CIK 1610520 ZURICH, V8
Back to DXCM Full portfolio

Position in DXCM

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$273,177,422
+$145,496,148 QoQ
Shares Held
4,349,959
+126.1% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 82% Shared 0% None 18%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Mar 31, 2026
CallValue
$30,966,428
CallShares
493,096
PutValue
$31,073,440
PutShares
494,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

UBS Group AG holds $5,158,506,137 across 134 Medical Devices names. DXCM ranks #5 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,152,765 $1,247,724,380
2 BSX
Boston Scientific Corp
 14,824,662 $930,247,536
3 MDT
Medtronic plc
 6,412,252 $555,621,633
4 SYK
Stryker Corp
 1,646,714 $541,093,748
5 DXCM
Dexcom Inc
This page 		4,349,959 $273,177,422
6 EW
Edwards Lifesciences Corp
 2,561,776 $205,147,019
7 GEHC
GE HealthCare Technologies Inc.
 2,805,315 $199,682,320
8 PEN
Penumbra Inc
 560,335 $183,997,200

All Filings in DXCM

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $31,073,440 494,800
2026-03-31 $30,966,428 493,096
2026-03-31 $273,177,422 4,349,959
2025-12-31 $50,991,805 768,296
2025-12-31 $127,681,274 1,923,780
2025-12-31 $40,001,199 602,700
2025-09-30 $45,508,227 676,300
2025-09-30 $198,917,447 2,956,122
2025-09-30 $44,377,755 659,500
2025-06-30 $25,671,989 294,100
2025-06-30 $168,704,595 1,932,691
2025-06-30 $31,616,438 362,200
2025-03-31 $29,788,098 436,200
2025-03-31 $25,991,174 380,600
2025-03-31 $136,205,084 1,994,510
2024-12-31 $39,896,010 513,000
2024-12-31 $27,499,472 353,600
2024-12-31 $151,471,536 1,947,686
2024-09-30 $36,959,152 551,300
2024-09-30 $29,095,360 434,000
2024-09-30 $94,681,527 1,412,314
2024-06-30 $135,748,850 1,197,291
2024-06-30 $32,335,976 285,200
2024-06-30 $27,807,578 245,260
2024-03-31 $154,326,356 1,112,663
2024-03-31 $32,963,442 237,660
2024-03-31 $32,525,150 234,500
2023-12-31 $20,909,165 168,500
2023-12-31 $22,703,506 182,960
2023-12-31 $127,592,810 1,028,228
2023-09-30 $100,142,434 1,073,338
2023-09-30 $18,380,100 197,000
2023-09-30 $33,979,860 364,200
2023-06-30 $24,596,814 191,400
2023-06-30 $16,333,621 127,100
2023-06-30 $121,674,166 946,807
2023-03-31 $7,238,014 62,300
2023-03-31 $8,237,162 70,900
2023-03-31 $71,035,238 611,424
2022-12-31 $11,032,067 97,422
2022-12-31 $138,379 1,222
2022-12-31 $75,429,163 666,100
2022-09-30 $4,027,000 50,000
2022-09-30 $28,101,208 348,910
2022-06-30 $32,928,318 441,813
2022-03-31 $65,598,373 128,222
2021-12-31 $99,517,236 185,338
2021-09-30 $97,589,898 178,455
2021-06-30 $2,135,000 5,000
2021-06-30 $60,377,800 141,400

Report a Problem

Category
Description
Email (optional, for follow-up)